Page 2 - Control Organisation News Today

New Delhi [India], August 7 (ANI): The Union Ministry of Chemicals and Fertilizers on Friday informed that facility augmentation of Bharat Biotech and three other public sector enterprises (PSEs) are being supported and for augmented production of Covaxin.

For treatment of mild to moderate Covid-19Roche India today announced that the Central Drugs Standards Control Organisation (CDSCO) has provided an Emergency Use Authorisation (EUA) for Roches antibody cocktail (Casirivimab and Imdevimab) in India. This approval was based on the data that have been filed for the EUA in the United States, and the scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) in the European Union. This Emergency Use Authorisation will now ena...

Unfounded and without basis: Harsh Vardhan on Chhattisgarh CMs concerns on Covaxin Chhattisgarh CM had raised two primary concerns regarding Covaxin -- inhibitions on incomplete trials and absence of "expiration date". Dr Vardhan says vaccine approved after due evaluation of pre-clinical and clinical trial data and that expiry date is mentioned on its label BusinessToday.In | February 12, 2021 | Updated 09:48 IST Union health minister Harsh Vardhan Union health minister Harsh Vardhan has writt...

Chhattisgarh minister wants Covaxin stopped, Harsh Vardhan asks why serve vested interests India Today Web Desk As Chhattisgarh Health Minister TS Singh Deo expressed doubts over the safety of Covaxin over the Bharat Biotech vaccine not completing Phase 3 trials yet, Union Health Minister Harsh Vardhan slammed the Congress leader saying it is not befitting of a state minister to cast doubts and serve vested interests. Covaxin safety concerns Harsh Vardhan has said both Covaxin ...

Chhattisgarh Health Minister T S Singh Deo said he had written to Harsh Vardhan urging him not to send Bharat Biotechs Covaxin till the phase-3 clinical trial results are completed.

Allaying concerns of Chhattisgarh over incomplete phase 3 trials of Covaxin, Union Health Minister Harsh Vardhan on Thursday said both this and the other COVID-19 vaccine Covishield are safe and immunogenic and should be used expeditiously to mitigate the impact of the pandemic.

India News: NEW DELHI: Allaying concerns of Chhattisgarh over incomplete phase 3 trials of Covaxin, Union health minister Harsh Vardhan on Thursday said both this.

A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport, which according to the officials will be used as a Covid-19 vaccine handling and distribution center, during the media preview in New Delhi, India on Dec 22. — Reuters/File NEW DELHI: India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter said. The decision clears the...